🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fascinating new paper from Manchester BRC’s COPD research team which evidences the science behind the COPD treatment guidelines on the use of steroid inhalers 👇 #WorldCOPDDay

Now published: our ERS publications article on the highlights of ERS Assembly 3 at ERS 2023. Thanks a lot to Sara Cuevas Ocaña for leading this - I'm already looking forward to ERS 2024! openres.ersjournals.com/content/early/…

NEW—GOLD COPD report: 2024 update thelancet.com/journals/lanre…

Current smoking reduces small airway eosinophil counts in COPD and controls. This provides evidence of an attenuation of T2 related inflammation in the small airways imposed by current smoking, which may affect ICS response. openres.ersjournals.com/content/early/… Medicines Evaluation Unit, an IQVIA business Immunology, Immunity to Infection, Respiratory Med

Check out the early career member led article: ''Research highlights from the 2023 European Respiratory Society International Congress: Airway diseases.'' 👇 openres.ersjournals.com/content/early/…

📖 Pre-order the ERS Monograph on COPD in the 21st Century! This new Monograph provides an up-to-date overview of what is happening in this field, both at a basic and clinical level Pre-order your print copy before 17 February to receive a €10 discount ersbookshop.com/products/copd-…

Recently published ERS monograph ''COPD in the 21st Century''. I am very grateful to have been given the opportunity to get involved in the writing of a chapter entitled: ''Eosinophils and COPD'' and look forward to having this monograph on my bookshelf!

Modern physiological measurement techniques (respiratory oscillometry, multiple-breath nitrogen washout and functional imaging) are clinically useful in COPD, but how do we get them into routine practice? @SteveMilne1010 Katrina Tonga Rachel Eddy bit.ly/ERSM103

📖 Order the ERS Monograph on COPD in the 21st Century now! This new Monograph provides an up-to-date overview of what is happening in this exciting field, both at a basic and a clinical level. Get your copy on the ERS bookshop: bit.ly/49XzgHL

COPD guidelines are updated regularly and easily accessible @ProfJVestbo bit.ly/ERSM103

The pharmacological agents for stable COPD are LABA/LAMA or SITT. SABA/LAMA combination is safe and more effecctive that LABA or LAMA monotherapy. Adding ICS is effective in a subset, particularly those with high blood eosinophil counts. Lies Lahousse bit.ly/ERSM103

A greater understanding of COPD patients and the molecular drivers behind their disease can facilitate new and better treatments. The focus need to be on precision medicine and early intervention to modify the disease course. Cara Flynn @Greening_COPD bit.ly/ERSM103

Coming soon to the ERS Respiratory Channel! A new interactive discussion series aiming to inform early career professionals about different career paths in respiratory medicine. We want to hear questions from YOU! 💡 Sachin Ananth ERS Early-Career Members

T2 inflammation is a shared treatable trait of some asthma and COPD patients, but the evidence reviewed here indicates that the nature of T2 inflammation is not identical in COPD and asthma. Eosinophilic COPD is not the same as asthma. bit.ly/3XdmwZW

The first episode of the ERS My Career Path series is online! It was a pleasure to organise this series with Dr Augusta (Gus) Beech The series highlights the different careers in respiratory medicine. A new episode will drop every month ERS Early-Career Members channel.ersnet.org/channel-327-my…